Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,4612,480 of 20,252 grants

Active NON-SBIR/STTR RPGS
Identifying and exploiting therapeutic vulnerabilities of tumor-host interactions that drive bone-to-meninges breast cancer metastasis
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2028

Leptomeningeal (LM) metastases occur in a wide variety of hematologic and solid malignancies, including leukemia, breast cancer (BC), and lung cancer. When LM metastases arise, the...

$4.95M
USD
Completed SBIR-STTR RPGS
The Alara Imaging Gateway: Linking Electronic Health Records and Radiology Imaging Exams to Report on National Quality Measures to Reduce Cancer Risk from Computed Tomography (Alara Imaging Gateway)
NATIONAL CANCER INSTITUTE Alara Imaging Inc United States 2023 – 2025

Abstract Alara Imaging, Inc. (Alara) is seeking funding to support the development of robust, IP-protected, HIPAA- compliant commercial quality software to calculate and report on...

$6.57M
USD
Active RESEARCH CENTERS
Project 3: Inter-Relationships and Prognostic Significance of Breast Cancer Radiomic Risk Features, Tissue Microenvironment, and Adiposity
NATIONAL CANCER INSTITUTE University of Hawaii At Manoa United States 2023 – 2026

SUMMARY / ABSTRACT The risk of breast cancer among U.S. women dramatically differs across racial and ethnic populations. Nonetheless, Asian American and Native Hawaiian/Pacific Isl...

Active RESEARCH CENTERS
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

CENTER OVERALL: PROGRAM SUMMARY / ABSTRACT While considerable evidence is available for screening and early treatment of breast and cervical cancers, huge gaps remain in equitable...

Active RESEARCH CENTERS
Core 1: Biostatistics & Bioinformatics Core
NATIONAL CANCER INSTITUTE University of Hawaii At Manoa United States 2023 – 2026

SUMMARY / ABSTRACT The goal of the Biostatistics and Bioinformatics Core (BBC) is to provide support to the SPORE projects, other cores, as well as the researchers funded through t...

Active NON-SBIR/STTR RPGS
The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in Puerto Rico.
NATIONAL CANCER INSTITUTE Comprehensive Cancer Center/ Univ/Pr United States 2023 – 2028

PROJECT SUMMARY Cervical cancer incidence is increasing dramatically (2.5% per year) in Puerto Rico (PR), with increased occurrence of regional (1.7% per year) and distant (4.7% pe...

$5.67M
USD
Active RESEARCH CENTERS
Core 2: Outreach & Recruitment Core
NATIONAL CANCER INSTITUTE University of Hawaii At Manoa United States 2023 – 2026

SUMMARY / ABSTRACT The Outreach and Recruitment Core (ORC) of this P50 application will play an integral role in the proposed research to achieve the overarching goal of maximizing...

Active RESEARCH CENTERS
Core 3: Pathology & Biospecimens Core
NATIONAL CANCER INSTITUTE University of Hawaii At Manoa United States 2023 – 2026

SUMMARY /ABSTRACT Access to relevant biospecimens is critical to translational research on minority populations. The lack of research specimens from racial and ethnic minority popu...

Active RESEARCH CENTERS
Developmental Research Program
NATIONAL CANCER INSTITUTE University of Hawaii At Manoa United States 2023 – 2026

SUMMARY The University of Hawai`i Cancer Center (UHCC) is the only National Cancer Institute-designated cancer center in Hawai`i and the Pacific. The Center's mission is to re...

Active RESEARCH CENTERS
Career Enhancement Program
NATIONAL CANCER INSTITUTE University of Hawaii At Manoa United States 2023 – 2026

SUMMARY The University of Hawai`i Cancer Center (UHCC) SPORE Career Enhancement Program (CEP) will identify and mentor investigators who show promise for independent research caree...

Active RESEARCH CENTERS
Next-Generation Engineered NK Cell Immunotherapy for Ovarian Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Project 2 SUMMARY/ ABSTRACT Ovarian cancer is the second most common gynecologic malignancy and remains the leading cause of gynecologic cancer deaths in the US. Therefore, there i...

Active NON-SBIR/STTR RPGS
Using microfluidics to realize patient-specific anti-cancer immunotherapies
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

Project Summary T cells play a central role in the immune response, detecting antigenic peptides cradled within MHC molecules (pMHCs) displayed on the surface of diseased cells via...

$10.81M
USD
Completed NON-SBIR/STTR RPGS
Sensitization to RIPK1-dependent death as a strategy to enhance response of renal cell carcinoma (RCC) to immunotherapy
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2023 – 2025

Abstract The use of anti-CTLA, anti-PD1 and anti-PD-L1, collectively known as immune checkpoint blockade (ICB), has revolutionized the treatment of cancer. The effectiveness of ICB...

$4.15M
USD
Active RESEARCH CENTERS
Targeting p300 to Overcome PARP inhibitor resistance induced by acidic tumor microenvironment
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Project 4 PROJECT SUMMARY/ABSTRACT The overall goal of this proposal is to develop a novel strategy to improve efficacy and/or overcome resistance to PARP inhibitors induced by aci...

Completed NON-SBIR/STTR RPGS
Unbiased electrothermal flow-enhanced identification of antigen-specific T cells in lung cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2025

Project Abstract/Summary Despite their success, immunotherapies fail to engage T cells on an antigen-dependent basis rather opting to reactivate a broad spectrum of T cells of unkn...

$4.13M
USD
Completed NON-SBIR/STTR RPGS
Cancer Emulation Analysis with Deep Neural Network
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2025

Project Summary To objectively quantify the relative effectiveness of drugs, devices, and treatment procedures on cancer prognosis, rigorously designed and executed randomized clin...

$1.68M
USD
Completed NON-SBIR/STTR RPGS
Developing an inhibitor of EIF2AK1 to overcome ineffective erythropoiesis in myelodysplastic syndromes with ringed sideroblasts
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2025

ABSTRACT Mutations in the splicing factor SF3B1 (SF3B1MT), which occur in 20% of patients with myelodysplastic syndromes (MDS), are the hallmarks of MDS-RS, an MDS subtype characte...

$3.79M
USD
Active NON-SBIR/STTR RPGS
Hyperpolarized 13C Metabolic Imaging of Tumorigenesis in the Liver
NATIONAL CANCER INSTITUTE Loyola University of Chicago United States 2023 – 2026

Project Summary. Aberrant glycolysis and mitochondrial function are features of most liver diseases including hepatocellular carcinoma (HCC). Despite these metabolic signatures, th...

$4.62M
USD
Completed SBIR-STTR RPGS
SaefCAR: Regulatable CAR-T cells for safe and effective immunotherapy
NATIONAL CANCER INSTITUTE Mabswitch, Inc United States 2023 – 2025

Project Summary: Despite the remarkable success in the treatment of some hematological cancers, the risk of serious adverse events and loss of potency remain major problems that th...

$4M
USD
Completed NON-SBIR/STTR RPGS
Development of an Anti-Cancer Approach Through a Novel Pathway of Translational Regulation
NATIONAL CANCER INSTITUTE Texas Tech University Health Scis Center United States 2023 – 2025

ABSTRACT STAT3 (Signal Transducer and Activator of Transcription 3) is a transcriptional regulator that plays crucial role in malignant transformation of the cells, tumor growth an...

$1.53M
USD